Abstract
Acute effects of oral calcium supplementation have been studied mainly in preand post-menopausal women, whereas very few data concerning men are available. We investigated the effects of 1.2 g of oral calcium administered for 4 days in 18 healthy young men. The day before the first calcium dosing (day −1) and the day of the last calcium dosing (day 4) total and ionized serum calcium and intact PTH were measured at multiple time-points up to 24 h; calcium, C-terminal telopeptide (CTX), pyridinoline (PYD) and deoxypyridinoline (DPD) were measured in urine collected every six h.
On day 4, total and ionized serum calcium increased during the 6 h following oral calcium: the maximum increase over baseline was 5.04 and 7.4% respectively, occurring after 2.9±1.9 h (mean±SD) and 2.6±0.9 h. The AUC was significantly higher on day 4 than on day −1 for both total serum calcium (+4.6%, p<0.02) and ionized serum calcium (+9.2%, p<0.0001). Twenty-four h urinary excretion of total calcium increased significantly on day 4 (+15.1%, p<0.02), mainly as a consequence of increased excretion during the first 6 h.
Serum PTH was suppressed by oral calcium, with a significant reduction of AUC on day 4 (− 15.1%, p<0.05). Serum concentrations of intact PTH dropped from 26.4±9.8 pg/ml at time zero to a minimum mean value of 14.9±7.6 pg/ml at time +2 h.
Bone resorption markers significantly decreased on day 4 (CTX −33.2%, p<0.001; PYD − 28.5%, p<0.05; DPD −35.8%, p<0.02). Most of the effect was seen in the first 6 h after oral calcium load.
These data support the concept that acute suppression of PTH and bone resorption induced by calcium administration is not gender specific and provide the rationale to further assess also in men the long-term effects of oral calcium in the prevention and treatment of osteoporosis.
Similar content being viewed by others
References
Francis R.M., Peacock M., Taylor G.A., Storer J.H., Nordin B.E.C. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites in the bowel. Clin. Sci. 1984, 66: 103–107.
Need A.G., Morris H.A., Horowitz M., Scopacasa F., Nordin B.E.C. Intestinal calcium absorption in men with spinal osteoporosis. Clin. Endocrinol. (Oxf.) 1998, 48: 163–168.
Blumsohn A., Herrington K., Hannon R.A., Shao P., Eyre D.R., Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. J. Clin. Endocrinol. Metab. 1994, 79: 730–735.
Scopacasa F., Horowitz M., Wishart J.M., et al. Calcium supplementation suppresses bone resorption in early post-menopausal women. Calcif. Tissue Int. 1998, 62: 8–12.
Rubinacci A., Divieti P., Polo R.M., Zampino M., Resmini G., Tenni R. Effect of an oral calcium load on urinary markers of collagen breakdown. J. Endocrinol. Invest. 1996, 19: 718–726.
Need A.G., Horowitz M., Philcox J.C., Nordin B.E.C. Biochemical effects of a calcium supplement in osteo-porotic women with normal absorption and malabsorption of calcium. Miner. Electrolyte Metab. 1987, 13: 112–116.
Dawson-Hughes B., Harris S.S., Krall E.A., Dallal G.E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N. Engl. J. Med. 1997, 337: 670–702.
Peacock M., Liu G., Carey M., et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J. Clin. Endocrinol. Metab. 2000, 85: 3009–3010.
Herfarth K., Drechsler S., Inhoff W., et al. Calcium regulating hormones after oral and intravenous calcium administration. Eur. J. Clin. Chem. Clin. Biochem. 1992, 30: 815–822.
Reginster J.Y., Denis D., Bartsch Y., Deroisy R., Zegels B. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporosis Int. 1993, 3: 271–275.
Horowitz M., Wishart J.M., Goh D., Morris H.A., Need A.G., Nordin B.E.C. Oral calcium suppresses biochemical markers of bone resorption in normal men. Am. J. Clin. Nutr. 1994, 60: 965–968.
Guillemant J., Le H., Maria A., Guillemant S. Acute effects of oral calcium load on parathyroid function and on bone resorption in young men. Am. J. Nephrol. 2000, 20: 48–52.
Delmas P.D., Gineyts E., Bertholin A., Garnero P., Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget’s disease. J. Bone Miner. Res. 1993, 8: 643–648.
Hanson D.A., Weis M.A.E., Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: Quantitation of Type I collagen cross-linked n-telopeptides in urine. J. Bone Miner. Res. 1992, 7: 1251–1258.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ortolani, S., Scotti, A. & Cherubini, R. Rapid suppression of bone resorption and parathyroid hormone secretion by acute oral administration of calcium in healthy adult men. J Endocrinol Invest 26, 353–358 (2003). https://doi.org/10.1007/BF03345184
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345184